International Childhood Cancer Day

The Tanzania Model as a shared research and clinical infrastructure in Africa

To mark International childhood Cancer Day on 15 February 2021, Tumaini la Maisha in collaboration with the AERAP Africa-EU Science Collaboration Platform will organise a virtual roundtable entitled “Childhood Cancer: The Tanzania Model as a shared research and clinical infrastructure in Africa”.

International Childhood Cancer Day is a global collaborative campaign to raise awareness about childhood cancer, and to express support for children and adolescents with cancer, the survivors and their families.

80% of children diagnosed with cancer are cured in high-income countries (HIC’s). 80% of childhood cancers globally occur in low-and-middle-income countries (LMIC’s) where survival rates are generally less than 20% of children affected.
In September 2018, the WHO Global Initiative for Childhood Cancer was launched. This aims for a survival rate of at least 60% for children with cancer to be attained by 2030, thereby saving an additional one million lives. This new target represents a doubling of the global cure rate for children with cancer.

“Too many children have their lives cut short by cancer, and survival rates in poor countries are scandalously lower than those in wealthy countries,” said Dr Tedros Adhanom Ghebreyesus, WHO Director-General.
The webinar will explore Tanzania’s efforts to change this paradigm. This East African country is meeting this challenge on many fronts including a national network of aligned clinical facilities; ground-breaking research partnerships; local expertise strengthening through multi-disciplinary university-based education; and the development of a range of highly innovative tools and support platforms specifically designed for children’s cancer services in resource-limited settings.

This will take the form of a strategic planning meeting.

13h Welcome Address

Barry Andrews MEP, Brussel, Belgium.
Omary Said Ubuguyu Non-communicable Disease Unit, Ministry of Health, Tanzania.

SDG’s linked to Collaborative Paediatric Oncology in Africa
Trish Scanlan We Are TLM (Tumaini la Maisha/Their Lives Matter)

Recognising Paediatric Oncology as a key priotiy for Africa-EU science collaboration in the area of health, leveraging Horizon Europe and the neighborhood, international cooperation and de development instrument, NDICI to increase sustainable cooperation.
Declan Kirrane ISC Intelligence in Science/AERAP

Participants invited to discuss the Collaborative Action needed including:


Jerry Ndumbalo Tanzanian Cancer Society, Ocean Road Cancer Institute, Tanzania
Laila Hessissen International Society of Paediatric oncology – President, SIOP Africa, Morocco
Joyce Kambugu International Society of Paediatric oncology, SIOP Africa, Uganda
Prof Laurence Museru Muhimbili University Hospital (MNH), Tanzania
Karim Assani Alliance Mondiale Contre le Cancer AMCC, Congo
Faraja Chiwanga Muhimbili National Hospital MNH, Tanzania
Hadija Mwamtemi Muhimbili National Hospital, MNH, Tanzania
Rehema Laiti Muhimbili National Hospital, MNH, Tanzania
Lulu Chirande MUHAS, Tanzania


Mary O’Neill Embassy of Ireland, Tanzania
Owen Smith University College Dublin UCD, Ireland
Pierre Bey Groupe Franco Africain d’Oncologie Pediatrique, GFAOP – President, France
Mary Horgan Royal College of Physicians of Ireland (RCPI) – President, Ireland
Jonathan Bond University College Dublin UCD Ireland
Anne Jones Genuity Science, Ireland
Rupert Handgretinger Children’s University Hospital & Tuebingen University, Germany


Kristin Schroeder Duke University, Bugando Medical Centre, BMC, Tanzania, United States.
Farhat Khanim Birmingham/Warwick Universities, United Kingdom
Martin Corbally Royal College of surgeons, Bahrain (RCSI)
Anna Schuh Seren Initiative, Oxford University
Nickhill Bhakta St Judes children’s research Hospital, United States
Joseph Lubega Global Hope/Baylor University/Texas Children’s Cancer Centre, United States

15h Closing and Action Points Confirmed.
International Childhood Cancer Day

The event is finished.


Feb 15 2021


1:00 PM - 3:00 PM


  • Anne Jones
    Anne Jones
    Chief Operating Officer, Genuity Science

    Anne Jones brings over 25 years’ experience working in the life science, chemical analysis and diagnostics arenas, in Ireland, the UK and the USA, working across a broad range of markets, products and functions.

    Prior to joining Genuity Science, Anne was Vice President and General Manager for Pall Corporations Lab, Food & Beverage business at US-based Danaher Corp. She also held senior roles in strategy development and planning at Agilent Technologies where she led business development and M&A activities for Agilent’s $2.3B Life Sciences and Applied Markets division and developed the strategy for Agilent’s successful entry into cell analysis. She also worked with Amersham Biosciences in the UK and GE Healthcare Life Sciences in the UK and USA in marketing and R&D roles.

    A graduate of National University of Ireland, Galway, in Microbiology and Molecular Biology, Anne completed her PhD at Cancer Research UK, studying protein biochemistry and molecular biology with focus on human DNA repair where she isolated a critical protein and elucidated its function in DNA repair, publishing this work in the highly-cited journals, ‘Nature’ and ‘J Biol. Chem’. Anne was recently recognized as one of The Top 25 Women Leaders in Biotechnology of 2020 by the The Healthcare Technology Report.

  • Barry Andrews
    MEP European Parliamentary Delegation for Relations with South Africa
  • Declan Kirrane
    Declan Kirrane
    Director ISC Intelligence in Science and Coordinator EU Africa Radio Astronomy Platform

    Declan Kirrane is Managing Director of ISC Intelligence in Science, a specialized science, technology and R&D public affairs firm based in Brussels, Belgium. ISC develops and implements Strategic Research Agendas for science and technology-based organisations in the EU and US.
    His practice areas cover IP, R&D consortia development, management and dissemination and is responsible for themes of ICT, health, security, defence, space and related policies, legislation, programmes and funding mechanisms. Declan Kirrane has a background in analysing the relationship between public and private R&D funding and the impact on R&D performance: he has worked extensively on science and technology policy evaluation methodologies and technology options for policy- and decision-makers. The EU’s Digital Agenda, emerging European space, security and defence policies are part of his remit.

  • Jonathan Bond
    Jonathan Bond
    Professor of Paediatric Molecular Haemato-oncology and Honorary Consultant Paediatric Haematologist at Children’s Health Ireland (CHI) at Crumlin

    Professor Jonathan Bond is the UCD Brendan McGonnell Professor of Paediatric Molecular Haemato-oncology and Honorary Consultant Paediatric Haematologist at Children’s Health Ireland (CHI) at Crumlin. Prof Bond originally trained as a clinical haematologist in Ireland before embarking on a scientific research career in the UK and France at UCL Institute of Child Health, the MRC London Institute of Medical Sciences at Imperial College London and Hôpital Necker-Enfants Malades in Paris.
    Prof Bond returned to Ireland in 2018 to lead a new collaborative paediatric leukaemia research programme between the National Children’s Cancer Service at CHI at Crumlin and Systems Biology Ireland at UCD. His group uses systems biology approaches to study the biology of high-risk paediatric blood cancers, with the ultimate aim of finding more precise and effective cures for children and adolescents with these diseases.

  • Mary Horgan
    Mary Horgan
    President of the Royal College of Physicians of Ireland

    Professor Mary Horgan is the President of the Royal College of Physicians of Ireland. She took up office as the 142nd President in October 2017 and was re-elected for a second three-year term in October 2020. She is the first woman President in RCPI’s 360 year history. Professor Horgan is a Consultant in infectious diseases with Cork University Hospital and Professor, School of Medicine, University College Cork. She is the Chair of National Research Ethics Committee and is a board member of the Health Products Regulatory Authority, Irish Blood Transfusion Service, University College Cork Governing Body, the Cork University Hospital Scientific Advisory Committee, and European Society of Clin Micro & Infectious Disease . She is a Committee Advisor on Return to Sports COVID-19, World Rugby and GAA. Originally from Kerry, Professor Horgan graduated from University College Dublin in 1986. She was awarded her MD in 1995, MRCPI in 1988 and FRCPI in 1997.

  • Owen Patrick Smith
    Owen Patrick Smith
    Professor of Paediatric and Adolescent Medicine at University College Dublin

    Owen Smith is Professor of Paediatric and Adolescent Medicine at University College Dublin, Consultant Paediatric Haematologist at Children’s Health Ireland at Crumlin and Chief Academic Lead to the Children Hospital Group. He is the National Clinical Lead for Child, Adolescent & Young Adult cancers at the National Cancer Control Programme. Professor Smith also holds the title, Honorary Regius Professor of Physic (1637) in the School of Medicine, Trinity College Dublin.

    The co-author of more than 380 research original articles, letters, books, book chapters and papers, Professor Smith is a Fellow of the Royal College of Paediatrics and Child Health, Royal College of Pathologists, Royal College of Physicians of Dublin, Royal College of Physicians London, Royal College of Physicians Glasgow, and Royal College of Physicians Edinburgh. He is a member of numerous associations and societies, including; the Medical Research Council Childhood Leukaemia Working Party, Children’s Oncology Group [USA], the International Berlin Frankfurt Munster Study Group for Childhood Leukaemia, the United Kingdom Children’s Cancer Group, European Working Group on paediatric aplastic anaemia and myelodysplastic syndromes. He is an international advocate for children and adolescents with rare diseases and for expanded access to expensive drugs.

    In 2015 Professor Smith was conferred honorary Commander in the Most Excellent Order of the British Empire (CBE) for his life-long work on cancer in children and adolescents by Queen Elizabeth, on the advice of the Foreign and Commonwealth Office.